Drug Trial Radar · NCT05303402
A Phase IIb/III Clinical Trial to Assess Safety and Immunogenicity of a COVID-19 Vaccine Booster Dose in Immunosupressed Adults.
Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
240
Actual
Start
May 12, 2022
Primary completion
Jan 9, 2024
Study completion Jan 9, 2024
Sponsor
- Lead sponsor
- Hipra Scientific, S.L.UIndustry
- Sponsor type
- Industry
- Collaborators
- Veristat, Inc.; Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia; Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta; Asphalion
- First posted
- Mar 31, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A phase IIb/III, open label, single arm, multi-centre, trial to assess the immunogenicity and safety of an additional dose vaccination with a recombinant protein RBD fusion heterodimer candidate (PHH-1V) against SARS-CoV-2, in adults with pre-existing immunosuppressive conditions vaccinated against COVID-19
Conditions
- SARS CoV 2 Infection
Interventions
PHH-1VBiological
COVID-19 Vaccine HIPRA, 40 mcg/dose
Primary outcomes
What the sponsor says the trial is designed to measure.
- Immunogenicity against Omicron, Beta, Delta at Day 0 and Day 14Time frame: Day 0 and Day 14
Locations
6 sites in 2 countries. Site status is shown where the registry gives one.
Hospital Germans Trias i Pujol
Badalona, Barcelona, Spain
Hospital Clínic de Barcelona
Barcelona, Barcelona, Spain
Hospital Josep Trueta
Girona, Girona, Spain
Hacettepe University Medical Faculty Hospitals
Ankara, Ankara, Turkey (Türkiye)
Ankara University Medical Faculty Hospitals
Ankara, Ankara, Turkey (Türkiye)
Koc University Hospital
Istanbul, Istanbul, Turkey (Türkiye)
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.